Repository logo
 
Publication

Limitations and perceived delays for diagnosis and staging of lung cancer in Portugal: A nationwide survey analysis

dc.contributor.authorBarata, Fernando
dc.contributor.authorFidalgo, Paula
dc.contributor.authorFigueiredo, Sara
dc.contributor.authorTonin, Fernanda S.
dc.contributor.authorDuarte-Ramos, Filipa
dc.date.accessioned2023-10-23T11:50:17Z
dc.date.available2023-10-23T11:50:17Z
dc.date.issued2021
dc.description.abstractBackground: We aimed to identify the perception of physicians on the limitations and delays for diagnosing, staging and treatment of lung cancer in Portugal. Methods: Portuguese physicians were invited to participate an electronic survey (Feb-Apr-2020). Descriptive statistical analyses were performed, with categorical variables reported as absolute and relative frequencies, and continuous variables with non-normal distribution as median and interquartile range (IQR). The association between categorical variables was assessed through Pearson's chi-square test. Mann-Whitney test was used to compare categorical and continuous variables (Stata v.15.0). Results: Sixty-one physicians participated in the study (45 pulmonologists, 16 oncologists), with n = 26 exclusively assisting lung cancer patients. Most experts work in public hospitals (90.16%) in Lisbon (36.07%). During the last semester of 2019, responders performed a median of 85 (IQR 55-140) diagnoses of lung cancer. Factors preventing faster referral to the specialty included poor articulation between services (60.0%) and patients low economic/cultural level (44.26%). Obtaining National Drugs Authority authorization was one of the main reasons (75.41%) for delaying the begin of treatment. The cumulative lag-time from patients' admission until treatment ranged from 42-61 days. Experts believe that the time to diagnosis could be optimized in around 11.05 days [IQR 9.61-12.50]. Most physicians (88.52%) started treatment before biomarkers results motivated by performance status deterioration (65.57%) or high tumor burden (52.46%). Clinicians exclusively assisting lung cancer cases reported fewer delays for obtaining authorization for biomarkers analysis (p = 0.023). Higher waiting times for surgery (p = 0.001), radiotherapy (p = 0.004), immunotherapy (p = 0.003) were reported by professionals from public hospitals. Conclusions: Physicians believe that is possible to reduce delays in all stages of lung cancer diagnosis with further efforts from multidisciplinary teams and hospital administration.pt_PT
dc.description.sponsorshiphis work was supported by AstraZeneca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscrippt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationBarata F, Fidalgo P, Figueiredo S, Tonin FS, Duarte-Ramos F. Limitations and perceived delays for diagnosis and staging of lung cancer in Portugal: A nationwide survey analysis. PLoS One. 2021;16(6):e0252529. doi:10.1371/journal.pone.0252529pt_PT
dc.identifier.doi10.1371/journal.pone.0252529pt_PT
dc.identifier.issn1932-6203
dc.identifier.urihttp://hdl.handle.net/10400.16/2836
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherPublic Library of Sciencept_PT
dc.relation.publisherversionhttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0252529pt_PT
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/pt_PT
dc.titleLimitations and perceived delays for diagnosis and staging of lung cancer in Portugal: A nationwide survey analysispt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.conferencePlaceUnited States of Americapt_PT
oaire.citation.issue6pt_PT
oaire.citation.startPagee0252529pt_PT
oaire.citation.titlePLOS ONEpt_PT
oaire.citation.volume16pt_PT
person.familyNameFidalgo
person.givenNamePaula
person.identifier.orcid0000-0002-6045-7059
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT
relation.isAuthorOfPublicationb1c895e3-9026-41d3-8cff-62c3debccfd2
relation.isAuthorOfPublication.latestForDiscoveryb1c895e3-9026-41d3-8cff-62c3debccfd2

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Barata-2021-Limitations-and-perceived-delays-fo.pdf
Size:
559.63 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.44 KB
Format:
Item-specific license agreed upon to submission
Description: